Neurological disorders are defined as a change in the function of the nervous system that primarily causes structural changes in the activity of the spinal cord, brain and other nerves. Neurological disorders are classified into three names, such as autonomic nervous system disorders, peripheral nervous system disorders, and central nervous system disorders. Most neurological disorders involve a gradual decrease in physical and mental abilities that disrupt the patient's life. Common neurological disorders include Alzheimer's disease, Parkinson's disease, Huntington's disease, neurological cancers and epilepsy. Therefore, neurotherapeutic products are used to treat patients with brain tumors or other neurological diseases.
The growth for Asia-Pacific Neurotherapeutics Market is driven due to factors like rising geriatric population, growing prevalence of neurological disorders, increasing demand for neurotherapeutic drugs, rising healthcare expenditure, and growing awareness about neuro treatments among people. In addition, increasing investments for R&D activities, advancement of technologies in neuro treatments, introduction of effective neurotherapeutic drugs and improving healthcare facilities in the developing nations are expected to drive the market growth. However, high cost of treatments, unfavorable reimbursement policy, limited skilled professionals are the restraining factors which is expected to hinder the growth rate for Asia-Pacific Neurotherapeutics Market during the forecast period.
Based on geography the Asia-Pacific Neurotherapeutics Market has been primarily divided into China, India, South Korea, Japan and Australia. China and India holds largest market share in the Neurotherapeutics Market due to increasing population, rising prevalence of neurological disorders and improving healthcare facilities are the driving factors in this region.